JP2024503898A5 - - Google Patents
Info
- Publication number
- JP2024503898A5 JP2024503898A5 JP2023544070A JP2023544070A JP2024503898A5 JP 2024503898 A5 JP2024503898 A5 JP 2024503898A5 JP 2023544070 A JP2023544070 A JP 2023544070A JP 2023544070 A JP2023544070 A JP 2023544070A JP 2024503898 A5 JP2024503898 A5 JP 2024503898A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163140523P | 2021-01-22 | 2021-01-22 | |
| US63/140,523 | 2021-01-22 | ||
| US202163202524P | 2021-06-15 | 2021-06-15 | |
| US63/202,524 | 2021-06-15 | ||
| PCT/US2022/070308 WO2022159976A1 (en) | 2021-01-22 | 2022-01-24 | Rapamycin analogs and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024503898A JP2024503898A (ja) | 2024-01-29 |
| JP2024503898A5 true JP2024503898A5 (https=) | 2025-02-03 |
| JPWO2022159976A5 JPWO2022159976A5 (https=) | 2025-02-03 |
Family
ID=82549982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023544070A Pending JP2024503898A (ja) | 2021-01-22 | 2022-01-24 | ラパマイシン類似体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220267352A1 (https=) |
| EP (1) | EP4281463A4 (https=) |
| JP (1) | JP2024503898A (https=) |
| KR (1) | KR20230136625A (https=) |
| AU (1) | AU2022209863A1 (https=) |
| BR (1) | BR112023014287A2 (https=) |
| CA (1) | CA3209086A1 (https=) |
| MX (1) | MX2023008634A (https=) |
| WO (1) | WO2022159976A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3914245A4 (en) | 2019-01-22 | 2022-08-24 | Aeovian Pharmaceuticals, Inc. | MTORC-1 MODULATORS AND USES THEREOF |
| WO2021195599A1 (en) | 2020-03-27 | 2021-09-30 | Aeovian Pharmaceuticals, Inc. | Mtorc1 modulators and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA935110B (en) * | 1992-07-17 | 1994-02-04 | Smithkline Beecham Corp | Rapamycin derivatives |
| JP2010500286A (ja) * | 2006-07-25 | 2010-01-07 | アボット・ラボラトリーズ | 結晶形態のラパマイシン類似体 |
| WO2011130232A1 (en) * | 2010-04-13 | 2011-10-20 | Novartis Ag | Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase (cdk4/6) inhibitor and an mtor inhibitor for treating cancer |
| EP2601201B1 (en) * | 2010-08-04 | 2014-09-24 | Meril Life Sciences Pvt. Ltd. | Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties" |
| US10683308B2 (en) * | 2015-09-11 | 2020-06-16 | Navitor Pharmaceuticals, Inc. | Rapamycin analogs and uses thereof |
| IL314362A (en) * | 2018-06-15 | 2024-09-01 | Janssen Pharmaceutica Nv | Rapamycin analogs and their uses |
| WO2020076738A2 (en) * | 2018-10-12 | 2020-04-16 | Bellicum Pharmaceuticals, Inc | Protein-binding compounds |
| EP3914245A4 (en) * | 2019-01-22 | 2022-08-24 | Aeovian Pharmaceuticals, Inc. | MTORC-1 MODULATORS AND USES THEREOF |
| KR20220128345A (ko) * | 2019-12-05 | 2022-09-20 | 아나쿠리아 테라퓨틱스, 인코포레이티드 | 라파마이신 유사체 및 이의 용도 |
-
2022
- 2022-01-24 JP JP2023544070A patent/JP2024503898A/ja active Pending
- 2022-01-24 CA CA3209086A patent/CA3209086A1/en active Pending
- 2022-01-24 US US17/648,750 patent/US20220267352A1/en not_active Abandoned
- 2022-01-24 AU AU2022209863A patent/AU2022209863A1/en not_active Abandoned
- 2022-01-24 MX MX2023008634A patent/MX2023008634A/es unknown
- 2022-01-24 BR BR112023014287A patent/BR112023014287A2/pt unknown
- 2022-01-24 KR KR1020237027812A patent/KR20230136625A/ko active Pending
- 2022-01-24 EP EP22743426.3A patent/EP4281463A4/en active Pending
- 2022-01-24 WO PCT/US2022/070308 patent/WO2022159976A1/en not_active Ceased